CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled StudyBruno P. Imbimbo, Mercedes Fernández, Sandra Sivilia et al.|Current Alzheimer Research|2013Cited by 78
Neural intersections of the phonological, visual magnocellular and motor/cerebellar systems in normal readers: Implications for imaging studies on dyslexiaLaura Danelli, Eraldo Paulesu, Manuela Berlingeri et al.|Human Brain Mapping|2012Cited by 55
Unrealistic representations of “the self”: A cognitive neuroscience assessment of anosognosia for memory deficitManuela Berlingeri, Eraldo Paulesu, A. Ravasio et al.|Consciousness and Cognition|2015Cited by 20
O3–06–05: Sustained cognitive benefit in patients with mild cognitive impairment (MCI) upon prolonged treatment with CHF5074Joel Ross, Bruno P. Imbimbo, Sanjiv Sharma et al.|Alzheimer s & Dementia|2013Cited by 3
Studio neuropsicologico di pazienti con epilessia non operati, pazienti con epilessia operati e controlli sani: Un confronto longitudinale a 5 anniA. Piazzini, Gabriella Bottini, P. Scarpa et al.|Unknown|2013Cited by 0